AJHO | Gotoper.com

Archive

Oncology Briefings™: Cases and Considerations in the Treatment of Hepatocellular Carcinoma

36th Annual Miami Breast Cancer Conference®

16th Annual Winter Lung Cancer Conference™

23rd Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma

35th Annual Miami Breast Cancer Conference®

22nd Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas and Myeloma®

2nd Annual International Congress on Oncology Pathology™

19th Annual International Lung Cancer Congress®

New York GU™: 11th Annual Interdisciplinary Prostate Cancer Congress® and other Genitourinary Malignancies

2nd Annual School of Nursing Oncology™

36th Annual CFS®: Innovative Cancer Therapy for Tomorrow

2nd Annual New York Cardio-Endo-Renal Collaborative (NY CERC)

December 2017

November 2017

October 2017

September 2017

August 2017

July 2017

June 2017

May 2017

April 2017

March 2017

February 2017

January 2017

December 2016

November 2016

October 2016

September 2016

August 2016

July 2016

June 2016

May 2016

April 2016

March 2016

February 2016

January 2016

December 2015

November 2015

October 2015

September 2015

August 2015

July 2015

June 2015

May 2015

April 2015

March 2015

February 2015

January 2015

December 2014

November 2014

September 2014

August 2014

Issues List

Oncology Briefings™: Cases and Considerations in the Treatment of Hepatocellular Carcinoma

36th Annual Miami Breast Cancer Conference®

16th Annual Winter Lung Cancer Conference™

23rd Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma

SUN	MON	TUES	WED	THURS	FRI	SAT
		1	2	3 Enduring CME Activity from the May 26, 2020 Live Webcast: COVID-19 and Cancer Care: What Oncologists Need to Know Today Expires on Jun 03, 2021 CME 1.0	4 Exploring the Advent of Antibody-Drug Conjugates Across Multiple Tumor Types: Implications for Testing and Treatment Planning (7:00 pm - 9:00 pm EDT) June 4, 2021 Live, Virtual Satellite Symposium CME 2.0 Rapid Fire Live Tumor Board™: Leveraging Clinical Data on CAR T to Inform Treatment Decision Making Across Heme Malignancies (7:00 pm - 9:00 pm EDT) June 4, 2021 Live, Virtual Satellite Symposium CME 2.0 Virtual AML Coffee Talk: Challenging the Experts on How They Treat Patients and Individualize Care with Novel Therapies (7:00 am - 8:30 am EDT) June 4, 2021 Virtual Satellite Symposium CME 1.5	5 Overcoming T Cell Exhaustion as a Resistance Mechanism in Immuno-Oncology Expires on Jun 05, 2021 CME 0.5 Ovarian Cancer Tumor Board: Leveraging Evolving Data Sets on PARP Inhibitors in Ovarian Cancer to Inform Treatment Decision-Making Expires on Jun 05, 2021 CME 1.5 Enduring CME Activity from the June 1, 2020 Live Webcast: COVID-19 and Cancer Care: What Oncologists Need to Know Today Expires on Jun 05, 2021 CME 1.0 2nd Annual Live Medical Crossfire®: Expert Exchanges in IBS and IBD June 5, 2021 Virtual Conference CME 6.25
6 Let’s Get “Real”: Minimizing Allograft Rejection in Renal Transplantation – Applying the Evidence to Real-World Scenarios (1:30 pm - 2:30 pm EDT) June 6, 2021 Virtual Symposium CME 1.0	7 Live Tumor Board! Experts Navigate the Impact of Neutropenia Across Tumor Types (7:00 pm - 9:00 pm EDT) June 7, 2021 Live, Virtual Satellite Symposium CME 2.0 Providing Patient-Centric Care in MDS and MPNs: Improving Outcomes and Quality of Life With New Therapeutic Options (7:00 pm - 9:00 pm EDT) June 7, 2021 Live Webcast CME 2.0 Medical Crossfire®: Current and Emerging Applications of Liquid Biopsies Across Cancer Care (7:00 pm - 9:00 pm EDT) June 7, 2021 Live, Virtual Satellite Symposium CME 2.0 Medical Crossfire®: Critical Conversations with the Surgeon: The Evolving Role of Immunotherapy for NSCLC Decision-Making in Curative Settings June 7, 2021 Live, Virtual Satellite Symposium CME 1.5	8 Top 10 Oncogenic Markers in Advanced NSCLC: What You Need to Know About Testing, Trials, and Novel Therapies (7:00 pm - 9:00 pm EDT) June 8, 2021 Live, Virtual Satellite Symposium CME 2.0 Uncovering New Multiple Myeloma Therapies and their Clinical Applications: Antibodies, CARs, BiTEs, and Beyond (7:00 pm - 9:00 pm EDT) June 8, 2021 Live, Virtual Satellite Symposium CME 2.0	9 Molecular Profiling to Differentiate Among Endometrial Cancers: The Evolving Use of Precision Medicine to Inform Management Now, and Advance Future Treatment Strategies (7:00 pm - 9:00 pm EDT) June 9, 2021 Live, Virtual Satellite Symposium CME 2.0 Show Me the Data®: Evidence-Based Strategies to Leverage Immunogenicity in Hepatocellular Carcinoma (7:00 pm - 9:00 pm EDT) June 9, 2021 Live, Virtual Satellite Symposium CME 2.0 EGFR Exon 20 NSCLC Tumor Board: Aligning Patient and Evidence to Inform Treatment Decisions in Real-World Care Scenarios (7:00 pm - 8:30 pm EDT) June 9, 2021 Live, Virtual Satellite Symposium CME 1.5	10 Exploring Current and Emerging Data Sets to Move Treatment of Higher-Risk MDS Forward: A Focus on Novel Targets and Treatment Approaches (7:00 pm - 9:00 pm EDT) June 10, 2021 Live, Virtual Satellite Symposium CME 2.0 Optimizing Outcomes in Cold Agglutinin Disease: Exploring the Impact of Rapid Diagnosis and Emerging Therapeutic Agents (16:00 pm - 17:30 pm CET) June 10, 2021 Live, Virtual Satellite Symposium CME 1.5 Show Me the Data! Managing Clinical Challenges in Advanced EGFR Mutation-Positive NSCLC (7:00 pm - 9:00 pm EDT) June 10, 2021 Live, Virtual Satellite Symposium CME 2.0	11 Clinical Briefings™: New Frontiers in Alpha-1 Antitrypsin Deficiency – Analyzing Diagnosis and the Efficacy of Available Therapies Expires on Jun 11, 2021 CME 1.0 Enduring CME Activity From the June 8, 2020, Live Webcast: COVID-19 and Cancer Care: What Oncologists Need to Know Today Expires on Jun 11, 2021 CME 1.0	12 Advances in™: Recent Developments in Diagnosis and Treatment of Mantle Cell Lymphoma Expires on Jun 12, 2021 CME 0.5 Transforming Outcomes in Relapsed and Refractory Multiple Myeloma With Antibody-Based Regimens: An Interactive Case-Based Discussion (17:45 pm - 19:15 pm CET) June 12, 2021 Live, Virtual Satellite Symposium CME 1.5
13	14	15 Clinical Briefings™: Promoting Excellence in the Care Of von Willebrand Disease Expires on Jun 15, 2021 CME 1.0 Renal Cell Carcinoma Playbook for Urologists: Emerging Strategies Across Lines of Therapy to Optimize Patient Outcomes Expires on Jun 15, 2021 CME 2.0 Addressing Clinical Gaps in Thyroid Cancer Management: New Agents, New Testing Paradigms, and Methods to Facilitate Multidisciplinary Care and Coordination (7:00 pm - 9:00 pm EDT) June 15, 2021 Live Webcast CME 2.0	16 Exploring Future Applications of HER2/3-Targeted Therapies Across Multiple Tumor Types Expires on Jun 16, 2021 CME 2.0 Show Me The Data™: How The Experts Make Evidence-Based Treatment Decisions in Prostate Cancer (7:00 pm - 9:00 pm EDT) June 16, 2021 Live Webcast CME 2.0 HER2-Positive Breast Cancer Tumor Board: Aligning Patient and Evidence to Inform Sequencing Decisions in Early and Advanced Disease Real-World Care (7:00 pm - 9:00 pm EDT) June 16, 2021 Live, Virtual Satellite Symposium CME 2.0	17 Bladder Cancer Playbook for Urologists: Practical Application of Current and Emerging Strategies to Optimize Patient Outcomes Expires on Jun 17, 2021 CME 2.0 Cases and Conversations™ in Advanced Renal Cell Carcinoma: Leveraging Landmark Evidence and Shared Decision-Making to Chart Personalized Care Trajectories (7:00 pm - 9:00 pm EDT) June 17, 2021 Live, Virtual Satellite Symposium CME 2.0 Head and Neck Cancers Multidisciplinary Tumor Board: Decision-Making Under Evolved Treatment Paradigms (7:00 pm - 8:30 pm EDT) June 17, 2021 Live, Virtual Satellite Symposium CME 1.5	18 Enduring CME Activity From the June 15, 2020, Live Webcast: COVID-19 and Cancer Care: What Oncology Nurses Need to Know Today, A Webcast Series–Week 13 Expires on Jun 18, 2021 CME 1.0	19 ASCO Direct Highlights™ - Dallas June 19, 2021 Dallas, TX CME 8.0
20	21	22 Medical Crossfire®: Exploring Novel Agents and Future Directions in GVHD Management Expires on Jun 22, 2021 CME 1.5 Top 10 Oncogenic Markers in Advanced NSCLC: What You Need to Know About Testing, Trials, and Novel Therapies (7:00 pm - 9:00 pm EDT) June 22, 2021 Live, Virtual Satellite Symposium CME 2.0 Illustrated Case Discussions: Practical Approaches to Treating Relapsed/Refractory DLBCL in 2021 (7:00 pm - 9:00 pm EDT) June 22, 2021 Live, Virtual Satellite Symposium CME 2.0	23 Reflective Case-Based Oncology Collective™: Real-World Applications for PARP Inhibition in Ovarian Cancer Clinical Practices (6:00 pm - 8:00 pm EDT) June 23, 2021 Live Webcast CME 2.0	24 Mentors in Medicine Series on Applied Precision Medicine: Focus on Where We Are in Melanoma After 10 Years With Immunotherapy (7:30 pm - 9:00 pm EDT) June 24, 2021 Live Webcast CME 1.5 A Virtual Exploration of Clinical Trial Evidence on XPO Inhibition Strategies: Translating Key Outcomes to the Practical Management of Relapsed/Refractory Hematologic Malignancies (7:00 pm - 9:00 pm EDT) June 24, 2021 Live, Virtual Satellite Symposium CME 2.0	25 Targeting HER2/3 in Advanced NSCLC: Where Are We and Where Are We Going? Expires on Jun 25, 2021 CME 1.5 Medical Crossfire®: Novel Applications of Liquid Biopsies Across Cancer Care Expires on Jun 25, 2021 CME 2.0 Enduring CME Activity From the June 22, 2020, Live Webcast: COVID-19 and Cancer Care: What Oncologists Need to Know Today: Focus on Managing Patients with Hematologic Malignancies Expires on Jun 25, 2021 CME 1.0	26 5th Annual International Congress on Oncology & Pathology™: Towards Harmonization of Pathology and Oncology Standards June 26, 2021 Virtual Conference Novel Interventions Targeting Itch Pathways in Skin Disease (2:35 pm - 3:35 pm PDT) June 26, 2021 Live, Virtual Satellite Symposium CME 1.0 ASCO Direct Highlights™ - Charlotte, NC June 26, 2021 Charlotte, NC CME 7.25 ASCO Direct Highlights™ - Las Vegas, NV June 26, 2021 Virtual Conference CME 7.25
27 Chronic Kidney Disease and T2DM: Evolving Strategies in Diagnosis and Treatment (6:45 pm - 8:15 pm EDT) June 27, 2021 Live, Virtual Satellite Symposium CME 1.5	28	29 Oncology Consultations®: Exploring Novel Agents and Future Directions in HER2-Positive Metastatic Breast Cancer Expires on Jun 29, 2021 CME 1.0 Oncology Briefings™: The Advent of Novel Treatment Approaches for SCLC Expires on Jun 29, 2021 CME 1.0 Medical Crossfire®: Improving Patient Outcomes in MDS Through Better Diagnosis, Risk Stratification, and New Treatment Options Expires on Jun 29, 2021 CME 1.5 Clinical Briefings™: Optimizing Management of Patients With PID Disorders- Challenges and Opportunities in Diagnosis and Treatment Expires on Jun 29, 2021 CME 1.0 Expert Perspectives in Relapsed/Refractory DLBCL: A Look to the Future of Care Expires on Jun 29, 2021 CME 2.0 Onco-Nurse Academy™: Navigating Melanoma Management With Targeted Therapies and Immunotherapies Expires on Jun 29, 2021 CME 1.5	30 Advances In™: The Emerging Role of MET Inhibitors Across NSCLC Treatment Expires on Jun 30, 2021 CME 1.0 Advances in™ Oncology Nursing: Recognizing and Treating Oncologic Emergencies in Patients With Cancer Expires on Jun 30, 2021 CME Advances In™ MDS and MPNs: Nursing Strategies for Disease and Anemia Management Expires on Jun 30, 2021 CME Community Practice Connections™: Ovarian Cancer Tumor Board: Leveraging Evolving Data Sets on PARP Inhibitors in Ovarian Cancer to Inform Treatment Decision-Making Expires on Jun 30, 2021 CME 1.5 Community Practice Connections™: The Latest Advances on PARP Inhibition in Ovarian Cancer: What You Need to Know Expires on Jun 30, 2021 CME 1.0 Clinical Briefings™: Advances in Anti-VEGF Therapies for Neovascular Age-Related Macular Degeneration Expires on Jun 30, 2021 CME 1.0 Medical Crossfire®: How Can We Maximize Immuno-Oncology Strategies in Small Cell Lung Cancers? Expires on Jun 30, 2021 CME 2.0 Integrating the Evidence to Optimize Treatment for Patients with Advanced RCC: An Expert Tumor Board Discussion Expires on Jun 30, 2021 CME 2.0 Medical Crossfire®: Emerging Applications to Optimize and Individualize AML Treatment Expires on Jun 30, 2021 CME 2.0 Maximizing the Potential of Cancer Immunotherapies: Collaborative Efforts to Refine Biomarker-Guided Immunotherapy Expires on Jun 30, 2021 CME 2.0